Alcon EPS - Earnings per Share 2019-2022 | ALC

Alcon annual and quarterly earnings per share history from 2019 to 2022. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Alcon EPS for the quarter ending September 30, 2022 was $0.23, a INF% increase year-over-year.
  • Alcon EPS for the twelve months ending September 30, 2022 was $1.15, a 71.64% increase year-over-year.
  • Alcon 2021 annual EPS was $0.76, a 169.72% decline from 2020.
  • Alcon 2020 annual EPS was $-1.09, a 18.66% decline from 2019.
  • Alcon 2019 annual EPS was $-1.34, a 191.3% increase from 2018.
Alcon Annual EPS
2021 $0.76
2020 $-1.09
2019 $-1.34
2018 $-0.46
Alcon Quarterly EPS
2022-09-30 $0.23
2022-06-30 $0.30
2022-03-31 $0.34
2021-12-31 $0.28
2021-09-30 $0.00
2021-06-30 $0.31
2021-03-31 $0.17
2020-12-31 $0.19
2020-09-30 $-0.30
2020-06-30 $-0.86
2020-03-31 $-0.12
2019-12-31 $-0.18
2019-09-30 $-0.14
2019-06-30 $-0.80
2019-03-31 $-0.22
2018-12-31 $0.00
2018-09-30 $-0.42
2018-06-30 $0.03
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $37.369B $8.291B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.951B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00